Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 645

2.
3.

Dynamic contrast-enhanced MRI to quantify VEGF-enhanced tissue-engineered bladder graft neovascularization: pilot study.

Cartwright L, Farhat WA, Sherman C, Chen J, Babyn P, Yeger H, Cheng HL.

J Biomed Mater Res A. 2006 May;77(2):390-5.

PMID:
16429423
4.
5.

Intraindividual in vivo comparison of gadolinium contrast agents for pharmacokinetic analysis using dynamic contrast enhanced magnetic resonance imaging.

Liang J, Sammet S, Yang X, Jia G, Takayama Y, Knopp MV.

Invest Radiol. 2010 May;45(5):233-44. doi: 10.1097/RLI.0b013e3181d54507.

PMID:
20351653
7.

Noninvasive monitoring of radiotherapy-induced microvascular changes using dynamic contrast enhanced magnetic resonance imaging (DCE-MRI) in a colorectal tumor model.

Ceelen W, Smeets P, Backes W, Van Damme N, Boterberg T, Demetter P, Bouckenooghe I, De Visschere M, Peeters M, Pattyn P.

Int J Radiat Oncol Biol Phys. 2006 Mar 15;64(4):1188-96. Epub 2006 Feb 2.

PMID:
16457965
8.

Dynamic contrast enhanced MRI of mouse fibrosarcoma using small-molecular and novel macromolecular contrast agents.

Ivanusa T, Beravs K, Medic J, Sersa I, Sersa G, Jevtic V, Demsar F, Mikac U.

Phys Med. 2007 Dec;23(3-4):85-90. Epub 2007 Jul 9.

PMID:
18061121
9.

Gadolinium-containing copolymeric chelates--a new potential MR contrast agent.

Unger EC, Shen D, Wu G, Stewart L, Matsunaga TO, Trouard TP.

MAGMA. 1999 Aug;8(3):154-62.

PMID:
10504042
10.

Uterine cervical carcinoma: comparison of standard and pharmacokinetic analysis of time-intensity curves for assessment of tumor angiogenesis and patient survival.

Hawighorst H, Knapstein PG, Knopp MV, Weikel W, Brix G, Zuna I, Schönberg SO, Essig M, Vaupel P, van Kaick G.

Cancer Res. 1998 Aug 15;58(16):3598-602.

11.

3D dynamic contrast-enhanced MRI of rectal carcinoma at 3T: correlation with microvascular density and vascular endothelial growth factor markers of tumor angiogenesis.

Zhang XM, Yu D, Zhang HL, Dai Y, Bi D, Liu Z, Prince MR, Li C.

J Magn Reson Imaging. 2008 Jun;27(6):1309-16. doi: 10.1002/jmri.21378.

PMID:
18504761
12.

The potential of contrast-enhanced magnetic resonance imaging for predicting left ventricular remodeling.

Watzinger N, Lund GK, Higgins CB, Wendland MF, Weinmann HJ, Saeed M.

J Magn Reson Imaging. 2002 Dec;16(6):633-40.

PMID:
12451576
13.

Comparison of tumor histology to dynamic contrast enhanced magnetic resonance imaging-based physiological estimates.

Aref M, Chaudhari AR, Bailey KL, Aref S, Wiener EC.

Magn Reson Imaging. 2008 Nov;26(9):1279-93. doi: 10.1016/j.mri.2008.02.015. Epub 2008 May 19.

PMID:
18487033
14.

Decrease in tumor apparent permeability-surface area product to a MRI macromolecular contrast medium following angiogenesis inhibition with correlations to cytotoxic drug accumulation.

Daldrup-Link HE, Okuhata Y, Wolfe A, Srivastav S, Øie S, Ferrara N, Cohen RL, Shames DM, Brasch RC.

Microcirculation. 2004 Jul-Aug;11(5):387-96.

PMID:
15280064
15.

AG-013736, a novel inhibitor of VEGF receptor tyrosine kinases, inhibits breast cancer growth and decreases vascular permeability as detected by dynamic contrast-enhanced magnetic resonance imaging.

Wilmes LJ, Pallavicini MG, Fleming LM, Gibbs J, Wang D, Li KL, Partridge SC, Henry RG, Shalinsky DR, Hu-Lowe D, Park JW, McShane TM, Lu Y, Brasch RC, Hylton NM.

Magn Reson Imaging. 2007 Apr;25(3):319-27. Epub 2007 Feb 5.

PMID:
17371720
16.

Dynamic contrast-enhanced (DCE) derived transfer coefficient (ktrans) is a surrogate marker of matrix metalloproteinase 9 (MMP-9) expression in brain tuberculomas.

Haris M, Husain N, Singh A, Awasthi R, Singh Rathore RK, Husain M, Gupta RK.

J Magn Reson Imaging. 2008 Sep;28(3):588-97. doi: 10.1002/jmri.21491.

PMID:
18777539
17.

Can pre-operative contrast-enhanced dynamic MR imaging for prostate cancer predict microvessel density in prostatectomy specimens?

Schlemmer HP, Merkle J, Grobholz R, Jaeger T, Michel MS, Werner A, Rabe J, van Kaick G.

Eur Radiol. 2004 Feb;14(2):309-17. Epub 2003 Oct 3.

PMID:
14531000
18.

Limitations of single slice dynamic contrast enhanced MR in pharmacokinetic modeling of bone sarcomas.

Toms AP, White LM, Kandel R, Bleakney RR, Noseworthy M, Lee S, Blackstein ME, Wunder J.

Acta Radiol. 2009 Jun;50(5):512-20. doi: 10.1080/02841850902922761.

PMID:
19431058
19.

Dynamic contrast-enhanced MRI measurements of passive permeability through blood retinal barrier in diabetic rats.

Berkowitz BA, Roberts R, Luan H, Peysakhov J, Mao X, Thomas KA.

Invest Ophthalmol Vis Sci. 2004 Jul;45(7):2391-8.

PMID:
15223822
20.

Supplemental Content

Support Center